journal article·2008-10-22

Nanoscaffold matrices for size-controlled, pulsatile transdermal testosterone delivery: nanosize effects on the time dimension

Ritu Malik, Shailesh Tondwal, K S Venkatesh, Amit Misra

Nanotechnology· Volume 19· Issue 43
Publisher page

Abstract

Pulsatile transdermal testosterone (T) has applications in hormone supplementation and male contraception. Pulsatile T delivery was achieved by assembling crystalline and nanoparticulate T in nucleation-inhibiting polymer matrices of controlled porosity. Different interference patterns observed from various polymeric films containing T were due to the various particle sizes of T present in the polymer matrices. Scanning electron microscopy was used to determine the size and shape of T crystals. Skin-adherent films containing T nanoparticles of any size between 10-500 nm could be prepared using pharmaceutically acceptable vinylic polymers. Drug release and skin permeation profiles were studied. The dissolution-diffusion behavior of nanoparticles differed from crystalline and molecular states. Nanosize may thus be used to engineer chronopharmacologically relevant drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hormonal and reproductive studies · Advancements in Transdermal Drug Delivery · Analytical Chemistry and Chromatography

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (24)

Show source-provided references
1. O’Donnell L · Knobil and Neill’s Physiology of Reproduction · 2005 · 1017
2. 10.1017/CBO9780511545221.00510.1017/CBO9780511545221.005 ↗
3. 10.1096/fj.06-07034210.1096/fj.06-070342 ↗
4. 10.1111/j.1365-2605.1993.tb01191.x10.1111/j.1365-2605.1993.tb01191.x ↗
5. 10.1111/j.1439-0272.1984.tb00407.x10.1111/j.1439-0272.1984.tb00407.x ↗
6. 10.1111/j.1439-0272.1985.tb01018.x10.1111/j.1439-0272.1985.tb01018.x ↗
7. 10.1210/jc.82.9.304010.1210/jc.82.9.3040 ↗
8. Morelli A · J. Endocrinol. Invest. · 2007 · 30 · 88010.1007/BF03349232 ↗
9. 10.1358/dot.2007.43.3.105079010.1358/dot.2007.43.3.1050790 ↗
10. 10.1002/14651858.CD004316.pub310.1002/14651858.CD004316.pub3 ↗
11. 10.1016/S0140-6736(06)68614-510.1016/S0140-6736(06)68614-5 ↗
12. 10.1023/A:101217952909010.1023/A:1012179529090 ↗
13. 10.1016/S0303-7207(99)00227-010.1016/S0303-7207(99)00227-0 ↗
14. 10.1021/nl070508110.1021/nl0705081 ↗
15. 10.1016/S0378-5173(00)00610-410.1016/S0378-5173(00)00610-4 ↗
16. Misra A · Proc. Int. Symp. Control. Rel. Bioact. Mater. · 1993 · 20 · 414
17. 10.1016/0168-3659(95)00122-010.1016/0168-3659(95)00122-0 ↗
18. 10.1016/j.jpba.2005.11.02110.1016/j.jpba.2005.11.021 ↗
19. 10.1039/b513392k10.1039/b513392k ↗
20. Roberts P J · J. Chem. Soc., Perkin Trans. · 1973 · 2 · 1973
21. 10.1016/j.addr.2007.07.00110.1016/j.addr.2007.07.001 ↗
22. 10.1016/j.biomaterials.2008.02.01610.1016/j.biomaterials.2008.02.016 ↗
23. 10.1016/j.ejpb.2006.04.00610.1016/j.ejpb.2006.04.006 ↗
24. 10.1080/0363904060108543310.1080/03639040601085433 ↗